Earnings Preview: Marinus Pharma
Portfolio Pulse from Benzinga Insights
Marinus Pharma (NASDAQ:MRNS) is set to release its latest quarterly earnings report on August 10, 2023. Analysts estimate an earnings per share (EPS) of $-0.72. The company's past performance shows a mixed trend of beating and missing EPS estimates, which has led to varying stock price changes. The company's shares were trading at $8.91 as of August 08, with a 48.61% increase over the last 52-week period.
August 09, 2023 | 4:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Marinus Pharma is set to release its Q2 2023 earnings. Analysts estimate an EPS of $-0.72. The company's past performance shows a mixed trend of beating and missing EPS estimates, which has led to varying stock price changes.
The upcoming earnings release is a significant event for Marinus Pharma. The company's past performance shows a mixed trend of beating and missing EPS estimates, which has led to varying stock price changes. This could indicate uncertainty in the market, leading to a neutral score.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100